UN special envoy to meet with Aung San Suu Kyi in Myanmar
The United Nations special envoy to Myanmar, Ibrahim Gambari, is scheduled to meet with opposition leader Aung San Suu Kyi on an official visit expected to start this weekend, government sources said Friday.
Gambari is expected to arrive in Yangon on Saturday to revive his so far unsuccessful efforts to push Myanmar's ruling junta to free Suu Kyi and thousands of other political prisoners and to allow democratic reforms in the military dictatorship.
On his last trip in August 2008, Gambari was denied an audience with military supremo Senior General Than Shwe. The UN special envoy also failed to meet with Suu Kyi, who has been under house arrest in her Yangon home since May 2003.
Suu Kyi reportedly judged a meeting then with Gambari as unnecessary as he had failed to meet with Than Shwe, the prime decision-maker in Myanmar.
It was unclear whether Gambari will be granted an interview with Than Shwe this trip, but government sources said the special envoy was scheduled to meet with Suu Kyi, members of the National League for Democracy (NLD) opposition party and some government ministers based in Yangon, formerly known as Rangoon.
Gambari was also scheduled to visit parts of the Irrawaddy Delta, which was devastated by cyclone Nargis in May last year.
The cyclone left 140,000 dead or missing, and 2.4 million in dire need of emergency assistance, the delivery of which was initially hampered by the military, but finally allowed in.
- Login or register to post comments
Print
Email to friend
Related Articles
- UN special envoy arrives in Yangon for talks with junta, opposition
- UN special envoy to Myanmar fails to see Aung San Suu Kyi
- Myanmar's Aung San Suu Kyi refuses food for three weeks
- Myanmar junta sends minister to meet Aung San Suu Kyi
- Myanmar's Aung San Suu Kyi accepts food after month-long protest
- Myanmar police chief clueless about Suu Kyi hunger strike
- "Up to ASEM" to pressure Myanmar, says Human Rights Watch
- Myanmar Supreme Court rejects new witnesses in Suu Kyi case
While, many stories have been written about the many aspects of health-care reform, there are few on how the Americans have reacted and responded...
According to data from a government-sponsored study, adding a triglyceride-lowering drug to cholesterol-fighting statins i. e Tricor, Abbott...
Abbott Laboratories hopes to win the US Food and Drug Administration’s (FDA) approval to launch its new device – MitraClip that has been designed...
International trials of Novartis AG’s blood pressure pill Diovan and diabetes drug Starlix show, which they neither prevent heart attacks, strokes...
A British fertility clinic is holding a raffle this week, with first prize a human egg by way or promoting its ‘baby profiling’ service, it...
Alarmed by the unjustified use of potentially cancer-causing CT scans, the Medicare watchdog and senior radiologists have been prompted to call on...
Increasingly, knee replacements are becoming one of the most common surgeries in America, as painful arthritis wears out the original knee which...
While, the elderly with failing memories often risk getting lost even on familiar streets, a study of Alzheimer’s patients suggests the risk is...
President Barack Obama’s healthcare bill has rallied support from Support from the Catholic Health Association, a group representing Catholic...
The debate over prostate specific antigen (PSA), the most commonly used prostate cancer screening procedure continues to grow, ever since its...
Dealing another blow to parents blaming vaccines for their children’s illness, a special U. S. court ruled Friday, vaccines containing thimerosal...
The US Food and Drug Administration (FDA) said Friday, a boxed warning will be added to Plavix, an $8-billion-a-year anti-clotting drug sold by...












